海泓
2021-11-04
鹰疃科技一定是只好股
暗盘:鹰瞳科技-B跌0.13%,三叶草生物-B跌超8%
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":848573376,"tweetId":"848573376","gmtCreate":1636015588437,"gmtModify":1636015588437,"author":{"id":4095420249490110,"authorId":4095420249490110,"authorIdStr":"4095420249490110","name":"海泓","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>鹰疃科技一定是只好股</p></body></html>","htmlText":"<html><head></head><body><p>鹰疃科技一定是只好股</p></body></html>","text":"鹰疃科技一定是只好股","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/848573376","repostId":1128117932,"repostType":4,"repost":{"id":"1128117932","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636013805,"share":"https://www.laohu8.com/m/news/1128117932?lang=&edition=full","pubTime":"2021-11-04 16:16","market":"us","language":"zh","title":"暗盘:鹰瞳科技-B跌0.13%,三叶草生物-B跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128117932","media":"老虎资讯综合","summary":"11月4日消息,鹰瞳科技-B暗盘报75港元,较发行价跌0.13%,公司每股定价75.1港元,每手100股;三叶草生物-B暗盘报12.24港元,较发行价跌8.52%,公司每股定价13.38港元,每手","content":"<p><b>11月4日消息,<a href=\"https://laohu8.com/S/02251\">鹰瞳科技-B</a>暗盘报75港元,较发行价跌0.13%,公司每股定价75.1港元,每手100股;<a href=\"https://laohu8.com/S/02197\">三叶草生物-B</a>暗盘报12.24港元,较发行价跌8.52%,公司每股定价13.38港元,每手500股。两只新股均将于11月5日(周五)港股上市。</b></p>\n<p><img src=\"https://static.tigerbbs.com/3fcf05637ae2795486a4b2d8a542b6a9\" tg-width=\"750\" tg-height=\"1286\" width=\"100%\" height=\"auto\"></p>\n<p><img src=\"https://static.tigerbbs.com/1ac1fd114bdaf434a6e125af374bd5dd\" tg-width=\"750\" tg-height=\"1292\" width=\"100%\" height=\"auto\"></p>\n<p><a href=\"https://laohu8.com/S/02251\">鹰瞳科技</a>-B在此前的公开认购阶段,共有14,309人申购,中签人数4,275人,一手中签率15.55%,认购7手稳中一手,超额认购6.18倍。</p>\n<p><a href=\"https://laohu8.com/S/02197\">三叶草生物-B</a>在此前的公开认购阶段,共有17,687人申购,中签人数8,795人,一手中签率35%,认购3手稳中一手,超额认购4.4倍。</p>\n<p>老虎资讯整理相关数据如下表:</p>\n<p><img src=\"https://static.tigerbbs.com/9737233ccdc69ca223654153da9af7c3\" tg-width=\"554\" tg-height=\"431\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/950365bc2d045b3e1f2c6ac768e7e53a\" tg-width=\"554\" tg-height=\"431\" referrerpolicy=\"no-referrer\"><b><a href=\"https://laohu8.com/S/02251\">鹰瞳科技</a></b>是国内最早的一批医疗AI企业之一,可以通过视网膜影像、多模态数据分析以及人工智能深度学习算法有别于慢性病传统的早期检测和辅助诊断方式,在医疗机构和大健康供应商中实现对慢性病的无创、准确、快速、有效且可扩展的检测与诊断。公司产品组合中拥有三个版本的Airdoc-AIFUNDUS(自主研发的核心产品)。</p>\n<p><b>三叶草生物</b>成立于2007年,是一家处于临床试验阶段的全球性生物技术公司,致力于为传染性疾病以及癌症及自身免疫性疾病开发新型疫苗及生物治疗候选产品。其主要产品于各治疗领域的适应症分别为COVID-19、恶性腹水及强直性脊柱炎。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>暗盘:鹰瞳科技-B跌0.13%,三叶草生物-B跌超8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n暗盘:鹰瞳科技-B跌0.13%,三叶草生物-B跌超8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-11-04 16:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>11月4日消息,<a href=\"https://laohu8.com/S/02251\">鹰瞳科技-B</a>暗盘报75港元,较发行价跌0.13%,公司每股定价75.1港元,每手100股;<a href=\"https://laohu8.com/S/02197\">三叶草生物-B</a>暗盘报12.24港元,较发行价跌8.52%,公司每股定价13.38港元,每手500股。两只新股均将于11月5日(周五)港股上市。</b></p>\n<p><img src=\"https://static.tigerbbs.com/3fcf05637ae2795486a4b2d8a542b6a9\" tg-width=\"750\" tg-height=\"1286\" width=\"100%\" height=\"auto\"></p>\n<p><img src=\"https://static.tigerbbs.com/1ac1fd114bdaf434a6e125af374bd5dd\" tg-width=\"750\" tg-height=\"1292\" width=\"100%\" height=\"auto\"></p>\n<p><a href=\"https://laohu8.com/S/02251\">鹰瞳科技</a>-B在此前的公开认购阶段,共有14,309人申购,中签人数4,275人,一手中签率15.55%,认购7手稳中一手,超额认购6.18倍。</p>\n<p><a href=\"https://laohu8.com/S/02197\">三叶草生物-B</a>在此前的公开认购阶段,共有17,687人申购,中签人数8,795人,一手中签率35%,认购3手稳中一手,超额认购4.4倍。</p>\n<p>老虎资讯整理相关数据如下表:</p>\n<p><img src=\"https://static.tigerbbs.com/9737233ccdc69ca223654153da9af7c3\" tg-width=\"554\" tg-height=\"431\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/950365bc2d045b3e1f2c6ac768e7e53a\" tg-width=\"554\" tg-height=\"431\" referrerpolicy=\"no-referrer\"><b><a href=\"https://laohu8.com/S/02251\">鹰瞳科技</a></b>是国内最早的一批医疗AI企业之一,可以通过视网膜影像、多模态数据分析以及人工智能深度学习算法有别于慢性病传统的早期检测和辅助诊断方式,在医疗机构和大健康供应商中实现对慢性病的无创、准确、快速、有效且可扩展的检测与诊断。公司产品组合中拥有三个版本的Airdoc-AIFUNDUS(自主研发的核心产品)。</p>\n<p><b>三叶草生物</b>成立于2007年,是一家处于临床试验阶段的全球性生物技术公司,致力于为传染性疾病以及癌症及自身免疫性疾病开发新型疫苗及生物治疗候选产品。其主要产品于各治疗领域的适应症分别为COVID-19、恶性腹水及强直性脊柱炎。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/09caddfc0c2d2ea28b3db992baa72dbf","relate_stocks":{"02251":"鹰瞳科技-B","02197":"三叶草生物-B"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128117932","content_text":"11月4日消息,鹰瞳科技-B暗盘报75港元,较发行价跌0.13%,公司每股定价75.1港元,每手100股;三叶草生物-B暗盘报12.24港元,较发行价跌8.52%,公司每股定价13.38港元,每手500股。两只新股均将于11月5日(周五)港股上市。\n\n\n鹰瞳科技-B在此前的公开认购阶段,共有14,309人申购,中签人数4,275人,一手中签率15.55%,认购7手稳中一手,超额认购6.18倍。\n三叶草生物-B在此前的公开认购阶段,共有17,687人申购,中签人数8,795人,一手中签率35%,认购3手稳中一手,超额认购4.4倍。\n老虎资讯整理相关数据如下表:\n鹰瞳科技是国内最早的一批医疗AI企业之一,可以通过视网膜影像、多模态数据分析以及人工智能深度学习算法有别于慢性病传统的早期检测和辅助诊断方式,在医疗机构和大健康供应商中实现对慢性病的无创、准确、快速、有效且可扩展的检测与诊断。公司产品组合中拥有三个版本的Airdoc-AIFUNDUS(自主研发的核心产品)。\n三叶草生物成立于2007年,是一家处于临床试验阶段的全球性生物技术公司,致力于为传染性疾病以及癌症及自身免疫性疾病开发新型疫苗及生物治疗候选产品。其主要产品于各治疗领域的适应症分别为COVID-19、恶性腹水及强直性脊柱炎。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1919,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":20,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/848573376"}
精彩评论